Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Biological Chemistry

Editor-in-Chief: Brüne, Bernhard

Editorial Board: Buchner, Johannes / Lei, Ming / Ludwig, Stephan / Thomas, Douglas D. / Turk, Boris / Wittinghofer, Alfred

IMPACT FACTOR 2018: 3.014
5-year IMPACT FACTOR: 3.162

CiteScore 2018: 3.09

SCImago Journal Rank (SJR) 2018: 1.482
Source Normalized Impact per Paper (SNIP) 2018: 0.820

See all formats and pricing
More options …
Volume 384, Issue 6


Isolation and Characterization of a Novel and Potent Inhibitor of Arg-Gingipain from Streptomyces sp. Strain FA-70

T. Kadowaki / S. Kitano / A. Baba / R. Takii / M. Hashimoto / N. Katunuma / K. Yamamoto
Published Online: 2005-06-01 | DOI: https://doi.org/10.1515/BC.2003.102


Arg-gingipain (Rgp) is a major cysteine proteinase produced by the oral bacterium Porphyromonas gingivalis, which is a major pathogen of advanced periodontal diseases. This enzyme is important for the bacterium both to exhibit its virulence and to survive in periodontal pockets. The development of Rgp inhibitors thus provides new therapeutic approaches to periodontal diseases. In this study, we first isolated and purified a novel and potent inhibitor of Rgp from the culture supernatant of Streptomyces species strain FA-70, now designated as FA-70C1. This compound was found to be an antipain analog composed of phenylalanyl-ureido-citrullinyl-valinyl-cycloarginal (C27H43N9O7). The Ki value was calculated to be 4.510 9 M when benzyloxycarbonyl-phenylalanylarginine-4-methly-coumaryl-7-amide was used as a substrate. This compound also inhibited cathepsins B, L, and H, though their Ki values were much higher than that of Rgp. FA-70C1 had little or no inhibitory activity on Lys-gingipain, another cysteine proteinase of P. gingivalis. The Rgp-induced degradation of various human proteins was completely blocked by this inhibitor. Disruption of both the bactericidal activity of polymorphonuclear leukocytes and the viability of human fibroblasts and umbilical vein endothelial cells induced by the culture supernatant of P. gingivalis was suppressed by the inhibitor in a dose-dependent manner. The enhancement of vascular permeability induced by in vivo administration of the culture supernatant of P. gingivalis was strongly inhibited by the inhibitor. Furthermore, the growth of P. gingivalis was suppressed by FA-70C1 in a dose-dependent manner. These results strongly suggest that FA-70C1 is a useful tool to prevent the virulence of P. gingivalis.

About the article

Published Online: 2005-06-01

Published in Print: 2003-06-16

Citation Information: Biological Chemistry, Volume 384, Issue 6, Pages 911–920, ISSN (Print) 1431-6730, DOI: https://doi.org/10.1515/BC.2003.102.

Export Citation

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

Saket Siddharth and Ravishankar V. Rai
Current Bioactive Compounds, 2019, Volume 15, Number 1, Page 19
Shinsuke Kataoka, Atsuyo Baba, Yoshimitsu Suda, Ryosuke Takii, Munetaka Hashimoto, Tomoyo Kawakubo, Tetsuji Asao, Tomoko Kadowaki, and Kenji Yamamoto
The FASEB Journal, 2014, Volume 28, Number 8, Page 3564
Masayuki Taniguchi, Yoshiyasu Matsuhashi, Takako K. Abe, Yohei Ishiyama, Eiichi Saitoh, Tetsuo Kato, Akihito Ochiai, and Takaaki Tanaka
Biopolymers, 2014, Volume 102, Number 5, Page 379
Mayumi TAIYOJI, Takashi YAMANAKA, Takuo TSUNO, and Sadami OHTSUBO
Bioscience, Biotechnology, and Biochemistry, 2013, Volume 77, Number 1, Page 80
Gesine Löhr, Thomas Beikler, Andreas Podbielski, Kerstin Standar, Sylvio Redanz, and Andreas Hensel
Journal of Clinical Periodontology, 2011, Volume 38, Number 5, Page 457
T. Beikler, U. Peters, K. Prior, B. Ehmke, and T. F. Flemmig
Journal of Periodontal Research, 2005, Volume 40, Number 3, Page 193

Comments (0)

Please log in or register to comment.
Log in